EICHOR
● Active Not Recruiting
A Study of Orforglipron (LY3502970) in Participants With Obesity or Overweight and at Least One Weight-Related Comorbidity
Condition: Obesity · Overweight · Sponsor: Eli Lilly and Company
About this study
The main purpose of this study is to see how orforglipron, compared with placebo, helps reduce body weight in participants with obesity or with overweight and at least one other related health condition (excluding type 2 diabetes). This trial is part of the master protocol study J2A-MC-GZPO (NCT06993792). Participation in the study will last about 18 months.
This description comes directly from the study's public registry record.
Talk to the study team
No contact information is available for this study as per the public registry record.
Always discuss trial participation with your own doctor first.
Locations (80)
| Clinical Research Institute of Arizona (CRI) - Sun City West | Sun City West, Arizona, United States | — |
| Novak Clinical Research - Tucson - North La Cholla Boulevard | Tucson, Arizona, United States | — |
| Norcal Endocrinology & Internal Medicine | San Ramon, California, United States | — |
| Southern California Clinical Research | Santa Ana, California, United States | — |
| Care Access - Thousand Oaks | Thousand Oaks, California, United States | — |
| Accel Research Sites - DeLand Clinical Research Unit | DeLand, Florida, United States | — |
| Innovation Medical Research Center - Fort Lauderdale | Fort Lauderdale, Florida, United States | — |
| Indago Research & Health Center, Inc | Hialeah, Florida, United States | — |
| Encore Medical Research | Hollywood, Florida, United States | — |
| West Orange Endocrinology P.A. | Ocoee, Florida, United States | — |
| Care Access - Tampa | Tampa, Florida, United States | — |
| Conquest Research | Winter Park, Florida, United States | — |
+ 68 more locations — full list on the registry record.
Follow this study
Save your interest here for when the public record changes — results posted, or the study's status changes. Email alerts for this study aren't switched on yet.
We keep this only about this public record, and never email you without alerts being switched on. Want it removed at any time? Email hello@eichor.com. Never medical advice. By subscribing you agree to our Terms of Use and Privacy Policy.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT06972459